EUVIMEDEUVIMED entdecken
Crossref

MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus

Huiting Zhang, Yi Jiang, Shenglan Zhu, Lijie Wei, Xuan Zhou, Peng Gao, Jingyi Zhang, Yuting Chen, Yuanyuan Du, Chenyun Fang, Rui Su, Jiaqi Li und 2 weitere

Placenta · 2024

DOI: 10.1016/j.placenta.2024.01.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta, 2024. Verfasst von Huiting Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, MicroRNAs, Insulin Resistance. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Gestational diabetes mellitus (GDM) is a prevalent pregnancy complication featuring impaired insulin sensitivity. MiR-155-5p is associated with various metabolic diseases. However, its specific role in GDM remains unclear. CCAAT enhancer binding protein beta (CEBPB), a critical role in regulating glucolipid metabolism, has been identified as a potential target of miR-155-5p. This study aims to investigate the impact of miR-155-5p and CEBPB on insulin sensitivity of trophoblasts in GDM. METHODS: Placental tissues were obtained from GDM and normal pregnant women; miR-155-5p expression was then evaluated by RT‒qPCR and CEBPB expression by western blot and immunohistochemical staining. To investigate the impact of miR-155-5p on insulin sensitivity and CEBPB expression, HTR-8/SVneo cells were transfected with either miR-155-5p mimic or inhibitor under basal and insulin-stimulated conditions. Cellular glucose uptake consumption was quantified using a glucose assay kit. Furthermore, the targeting relationship between miR-155-5p and CEBPB was validated using a dual luciferase reporter assay. RESULTS: Reduced miR-155-5p expression and elevated CEBPB expression were observed in GDM placentas and high glucose treated HTR8/SVneo cells. The overexpression of miR-155-5p significantly enhanced insulin signaling and glucose uptake in trophoblasts. Conversely, inhibiting miR-155-5p induced the opposite effects. Additionally, CEBPB was directly targeted and negatively regulated by miR-155-5p in HTR8/SVneo cells. Silencing CEBPB effectively restored the inhibitory effect of miR-155-5p downregulation on insulin sensitivity in trophoblasts. DISCUSSION: These findings suggest that miR-155-5p could enhance insulin sensitivity in trophoblasts by targeting CEBPB, highlighting the potential of miR-155-5p as a therapeutic target for improving the intrauterine hyperglycemic environment in GDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalMicroRNAsInsulin ResistanceHumansFemalePregnancyPlacentaCCAAT-Enhancer-Binding Protein-betaTrophoblastsGlucoseInsulinCell Proliferation

Stichwörter der Autor:innen

CEBPBGestational diabetes mellitusHTR8/SVneo cellsInsulin sensitivitymiR-155-5p

Substanzen

MicroRNAsCCAAT-Enhancer-Binding Protein-betaGlucoseInsulinCEBPB protein, humanMIRN155 microRNA, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Department of Obstetrics and Gynecology Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
  • Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: fltj007@163.com.

Zitieren

APA

Zhang, H., Jiang, Y., Zhu, S., Wei, L., Zhou, X., Gao, P., Zhang, J., Chen, Y., Du, Y., Fang, C., Su, R., Li, J., Wang, S., & Feng, L. (2024). MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus. Placenta. https://doi.org/10.1016/j.placenta.2024.01.011

Vancouver

Zhang H, Jiang Y, Zhu S, Wei L, Zhou X, Gao P, et al. MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus. Placenta. 2024. doi:10.1016/j.placenta.2024.01.011

BibTeX
@article{Zhang2024,
  author = {Zhang, Huiting and Jiang, Yi and Zhu, Shenglan and Wei, Lijie and Zhou, Xuan and Gao, Peng and Zhang, Jingyi and Chen, Yuting and Du, Yuanyuan and Fang, Chenyun and Su, Rui and Li, Jiaqi and Wang, Shaoshuai and Feng, Ling},
  title = {MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus},
  journal = {Placenta},
  year = {2024},
  doi = {10.1016/j.placenta.2024.01.011}
}
Kostenlos starten →